n -羟基吡啶二酮支持优化HBV核糖核酸酶H抑制剂的药理学评价

{"title":"n -羟基吡啶二酮支持优化HBV核糖核酸酶H抑制剂的药理学评价","authors":"Molly E. Woodson, M. Mottaleb, Grigoris Zoidis, J. Tavis","doi":"10.1124/jpet.122.193530","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":173142,"journal":{"name":"ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacological evaluation ofN-hydroxypyridinediones to support optimization as HBV ribonuclease H inhibitors\",\"authors\":\"Molly E. Woodson, M. Mottaleb, Grigoris Zoidis, J. Tavis\",\"doi\":\"10.1124/jpet.122.193530\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":173142,\"journal\":{\"name\":\"ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development\",\"volume\":\"5 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1124/jpet.122.193530\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1124/jpet.122.193530","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}